Development of orally bioavailable prodrugs of fulvestrant for the treatment of metastatic/advanced breast cancer.
用户Kn4EO1VuT6mQ
4小时前
16
10
已关闭
DOI: 10.1200/jco.2021.39.15_suppl.e13027
文献链接: https://ascopubs.org/doi/10.1200/JCO.2021.39.15_suppl.e13027
其他信息:
出版社: American Society of Clinical Oncology (ASCO)
作者: Parva Purohit; Pathik Brahmkshatriya; Vishalgiri Goswami